A light-activated morphine derivative relieves pain in mice
Medicinal chemists and pharmacologists have shed a lot of solvent in the quest to develop a painkiller…
New composite outcomes data show patients treated with Lilly’s Omvoh (mirikizumab-mrkz) achieved comprehensive corticosteroid-free disease control in ulcerative colitis and corticosteroid-free deep remission in Crohn’s disease at one year
In LUCENT-2, more than one in four (27.7%) Omvoh-treated patients with ulcerative colitis achieved comprehensive disease control, a…
Supplement sector rising, ‘safety needs to evolve with it’
Speaking during a webinar hosted by the International Alliance of Dietary and Food Supplement Associations (IADSA) last week,…
UnitedHealth Group (UNH) earnings Q3 2026
UnitedHealth Group signage on the floor of the New York Stock Exchange on April 21, 2025. Michael Nagle…
USFDA’s gummy study, Australia’s rules on andrographis in regulatory round-up
The mature dietary supplement market has been drawing increasing scrutiny from regulators, inspectors and legacy supplement brands. (Colorsandia…
Probing the many benefits of GLP-1 receptor agonists
RESEARCH HIGHLIGHT 05 October 2026 Glucagon-like peptide 1 (GLP-1) receptor agonists are approved for the treatment of type…
Eli Lilly, NIH grants, Novartis, Regeneron: Readout Newsletter
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter…
COVID-19 immunity shows cross-reactivity against related bat coronaviruses
People who recovered from COVID-19 infection or were vaccinated against SARS-CoV-2 are more likely to have immunity to…
Eli Lilly obesity drug with amylin, tirzepatide boosts weight loss in trial
Eli Lilly on Wednesday said its experimental combination regimen resulted in greater weight loss than a high dose…
Lilly’s triple agonist, retatrutide, delivered substantial weight loss and A1C reduction, underscoring its potential promise for people with obesity and type 2 diabetes
In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6…
Novo’s Wegovy pill improves weight loss after switch from injections
People who switched from obesity injections to Novo‘s new Wegovy pill continued to lose weight after three months,…
Smart farming, agri-startups take centre stage at UAS Krishi Mela | Hubballi News
Startup entrepreneurs demonstrate an autonomous precision spraying drone for targeted pesticide application during the Krishi Mela at the…